 |
lisinopril oral solution |
|---|---|
| Trade Name | |
| Orphan Indication | Hypertension in pediatric patients 0 through 16 years of age |
| USA Market Approval | USA |
| USA Designation Date | 2015-10-14 00:00:00 |
| Sponsor | Silvergate Pharmaceuticals, Inc.;6251 Greenwood Plaza Blvd., Suite 101;Greenwood Village, Colorado, 80111 |
